Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

To get screened for cervical cancer, patients in the United States may no longer need to put their feet in those awkward ...

Per a memo obtained by FedScoop, the NSF already started a reduction-in-force of its senior executive service and is ...

Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first ...

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

- Cash Position: Cash and cash equivalents were $101.6 million as of March 31, 2025, compared to $34.6 million as of December 31, 2024, bolstered by $76.4 million in gross proceeds from the first ...

The “blue economy” emerged as a popular vision for sustainable ocean development during the 2010s, as communities across the ...

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

For the first time in the United States, women can now screen for cervical cancer from the privacy of their own homes—no ...

Study will evaluate OX-4224 as a second-line monotherapy in patients with PD-L1–positive non-small cell lung cancer, expanding potential access to checkpoint ...